Quality of life reporting in kidney cancer clinical trials
Quality-of-life (QoL) is very important to patients when they are [...]
Quality-of-life (QoL) is very important to patients when they are [...]
Hospital Pharmacy Europe reported that the number of cancer patients [...]
The first patient has been enrolled in the AURORAX-087A study [...]
The COVID-19 pandemic has resulted in a number of changes [...]
In this article published in Cancer Therapy Advisor this week, [...]
Research from University College London published in PLOS One estimated [...]
A randomised clinical trial of hypoxia inducible factor 2α (HIF-2α) [...]
A retrospective study of the use of targeted therapies for [...]
Results from the International Kidney Cancer Coalition (IKCC) global patient [...]
In this article, Deb Maskens, founder of Kidney Cancer Canada [...]